Trial Outcomes & Findings for Implementing mHealth for Schizophrenia in Community Mental Health Settings (NCT NCT04147897)

NCT ID: NCT04147897

Last Updated: 2025-11-24

Results Overview

The Green Paranoid Thoughts Scale (GPTS)- part B measures ideas of persecution. Scores range from 16-80. Higher scores represent more severe symptoms.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

299 participants

Primary outcome timeframe

0,3,6 months

Results posted on

2025-11-24

Participant Flow

Participant milestones

Participant milestones
Measure
External Facilitation
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Enrolled in study
STARTED
176
123
Enrolled in study
Completed baseline
157
117
Enrolled in study
COMPLETED
157
117
Enrolled in study
NOT COMPLETED
19
6
3M Follow up
STARTED
157
117
3M Follow up
COMPLETED
101
85
3M Follow up
NOT COMPLETED
56
32
6M Follow Up
STARTED
101
85
6M Follow Up
COMPLETED
82
70
6M Follow Up
NOT COMPLETED
19
15

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Analyzed includes only those that completed baseline assessment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Total
n=274 Participants
Total of all reporting groups
Sex/Gender, Customized
Gender · Male
64 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
75 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
139 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Sex/Gender, Customized
Gender · Female
45 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
72 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
117 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Sex/Gender, Customized
Gender · Trandgender
4 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
8 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Sex/Gender, Customized
Gender · Other
4 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
8 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Sex/Gender, Customized
Gender · Unknown
0 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
9 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
12 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
Asian
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
5 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
3 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
Black or African American
12 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
17 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
29 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
White
81 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
108 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
189 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
More than one race
13 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
18 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
31 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
0 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Ethnicity (NIH/OMB)
Hispanic or Latino
16 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
17 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
33 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Ethnicity (NIH/OMB)
Not Hispanic or Latino
99 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
136 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
235 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
4 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
No formal school
3 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
3 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
6 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
Grade school
1 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
3 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
Junior high
8 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
9 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
17 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
High school diploma/GED
72 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
109 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
181 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
Associate's degree
22 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
19 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
41 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
Bachelor's degree or higher
11 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
14 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
25 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Education
Unknown
0 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
1 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
1 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Age, Continuous
43 Years
STANDARD_DEVIATION 12 • n=45 Participants • Analyzed includes only those that completed baseline assessment
43.6 Years
STANDARD_DEVIATION 11.7 • n=12929 Participants • Analyzed includes only those that completed baseline assessment
43.4 Years
STANDARD_DEVIATION 11.8 • n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Unable to work / Disabled
74 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
102 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
176 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Unemployed but looking for work
14 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
13 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
27 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Unemployed but not looking for work
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
7 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
9 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Employed full time
6 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
11 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
17 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Employed part time
14 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
12 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
26 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Student
5 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
7 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
12 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Employment
Retired
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
5 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
7 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Housing
Own/rent home or apartment
78 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
99 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
177 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Housing
Friend's home or apartment
23 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
31 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
54 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Housing
Mental health/substance use treatment facility or halfway house
13 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
15 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
28 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Housing
Homeless
2 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
11 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
13 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment
Housing
Unknown
1 Participants
n=45 Participants • Analyzed includes only those that completed baseline assessment
1 Participants
n=12929 Participants • Analyzed includes only those that completed baseline assessment
2 Participants
n=6349 Participants • Analyzed includes only those that completed baseline assessment

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Patient Health Questionnaire (PHQ)-9 is the major depressive disorder (MDD) module of the full PHQ. Total scores range from 0-27. Higher scores represent more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Patient Health Questionnaire (PHQ)-9
Baseline
11.6 Scores on scale
Standard Error 0.5
10.7 Scores on scale
Standard Error 0.6
Patient Health Questionnaire (PHQ)-9
3M Follow-up
9.6 Scores on scale
Standard Error 0.6
10.2 Scores on scale
Standard Error 0.7
Patient Health Questionnaire (PHQ)-9
6M Follow-up
9.3 Scores on scale
Standard Error 0.7
9.4 Scores on scale
Standard Error 0.7

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Generalized Anxiety Disorder-7 (GAD-7) measures generalized anxiety disorder symptoms. GAD-7 total score ranges from 0 to 21. Higher scores represent more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Generalized Anxiety Disorder-7 (GAD-7)
Baseline
9.3 Scores on scale
Standard Error 0.5
9 Scores on scale
Standard Error 0.6
Generalized Anxiety Disorder-7 (GAD-7)
3M Follow-up
7.6 Scores on scale
Standard Error 0.6
7.9 Scores on scale
Standard Error 0.6
Generalized Anxiety Disorder-7 (GAD-7)
6M Follow-up
7.9 Scores on scale
Standard Error 0.7
7.6 Scores on scale
Standard Error 0.6

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Insomnia Severity Index (ISI) is a brief screening assessment tool designed to evaluate insomnia. Total scores range from 0-28. Higher scores represent more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Insomnia Severity Index (ISI)
Baseline
12.4 Scores on scale
Standard Error 0.7
12.4 Scores on scale
Standard Error 0.6
Insomnia Severity Index (ISI)
3M Follow-up
11.4 Scores on scale
Standard Error 0.8
11.9 Scores on scale
Standard Error 0.7
Insomnia Severity Index (ISI)
6M Follow-up
12.6 Scores on scale
Standard Error 0.8
11.1 Scores on scale
Standard Error 0.7

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Green Paranoid Thoughts Scale (GPTS)- part B measures ideas of persecution. Scores range from 16-80. Higher scores represent more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Green Paranoid Thoughts Scale- Part B
3M Follow-up
31.6 Scores on scale
Standard Error 1.8
30.4 Scores on scale
Standard Error 1.6
Green Paranoid Thoughts Scale- Part B
6M Follow-up
32.4 Scores on scale
Standard Error 1.9
30.1 Scores on scale
Standard Error 1.7
Green Paranoid Thoughts Scale- Part B
Baseline
31.8 Scores on scale
Standard Error 1.7
32.5 Scores on scale
Standard Error 1.4

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Symptom Check List-9 (SCL-9) is a brief version of the SCL-90, which aims to evaluate a broad range of psychological problems and symptoms of psychopathology. Total scores are calculated as sum of all responses. Total sum scores range from 0-36. Higher scores mean more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Symptom Check List (SCL-9)
Baseline
13.7 Scores on scale
Standard Error 0.8
13 Scores on scale
Standard Error 0.9
Symptom Check List (SCL-9)
3M Follow-up
11.2 Scores on scale
Standard Error 0.9
11.7 Scores on scale
Standard Error 1.0
Symptom Check List (SCL-9)
6M Follow-up
10.7 Scores on scale
Standard Error 0.9
11.3 Scores on scale
Standard Error 1.0

PRIMARY outcome

Timeframe: 0,3,6 Months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

A 9-item measure specifically designed to quantify characteristics of auditory hallucinations including frequency, negative content, loudness, duration, interference with life, distress, impact on self-appraisal, and compliance with commands. Total score is a sum of all 9 items. Total HPSVQ scores range from 0-36. Higher scores mean more severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=117 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=157 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
Baseline
14.3 Scores on scale
Standard Error 1.0
13.8 Scores on scale
Standard Error 0.9
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
3M Follow-up
13.6 Scores on scale
Standard Error 1.1
12.5 Scores on scale
Standard Error 1.0
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
6M Follow-up
13.0 Scores on scale
Standard Error 1.2
11.5 Scores on scale
Standard Error 1.0

PRIMARY outcome

Timeframe: 0,3,6 months

Population: Baseline analyses include only those participants who completed baseline assessments (N=274; EF=157, IF=117). Participants who did not complete baseline assessments were excluded from analysis. 3M analyses include only those participants who completed 3M follow-up assessments (N= 186, EF=101, IF=85). 6M analyses include only those participants who completed 6M assessments (N=152, EF=82, IF=70).

The Illness Management and Recovery Scales (IMRS) measure illness management and recovery. Scoring is a sum of all responses ranging from 15-75. Higher scores mean less severe symptoms.

Outcome measures

Outcome measures
Measure
External Facilitation
n=157 Participants
mHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Internal Facilitation
n=117 Participants
mHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
Illness Management and Recovery Scales (IMRS)
Baseline
49.7 Scores on scale
Standard Error 0.7
49.8 Scores on scale
Standard Error 0.8
Illness Management and Recovery Scales (IMRS)
3M Follow-up
51.0 Scores on scale
Standard Error 0.8
50.7 Scores on scale
Standard Error 0.9
Illness Management and Recovery Scales (IMRS)
6M Follow-up
50.4 Scores on scale
Standard Error 0.8
51.2 Scores on scale
Standard Error 0.9

Adverse Events

External Facilitation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Internal Facilitation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dror Ben-Zeev, Professor

University of Washington

Phone: 206-685-9655

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place